114 related articles for article (PubMed ID: 12421497)
1. [The role of hyperhomocysteinemia on atherosclerosis in patients with chronic renal failure].
Yu Y; Hou F; Zhou H; Yang Y; Zhang X; Yang L; Hu M
Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):517-21. PubMed ID: 12421497
[TBL] [Abstract][Full Text] [Related]
2. [Hyperhomocysteinemia, oxidative stress and microinflammation in chronic renal failure: their roles in atherogene].
Yu YM; Hou FF; Zhang X; Zhou H; Liu ZQ
Zhonghua Nei Ke Za Zhi; 2004 Apr; 43(4):292-5. PubMed ID: 15130417
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine and carotid atherosclerosis in chronic renal failure--the confounding effect of renal function.
Leskinen Y; Lehtimäki T; Loimaala A; Huhtala H; Salenius JP; Oja SS; Saha H
Atherosclerosis; 2004 Aug; 175(2):315-23. PubMed ID: 15262188
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinemia, diabetes mellitus, and carotid atherosclerosis independently increase atherosclerotic vascular disease outcome in Japanese patients with end-stage renal disease.
Haraki T; Takegoshi T; Kitoh C; Kajinami K; Wakasugi T; Hirai J; Shimada T; Kawashiri M; Inazu A; Koizumi J; Mabuchi H
Clin Nephrol; 2001 Aug; 56(2):132-9. PubMed ID: 11522090
[TBL] [Abstract][Full Text] [Related]
5. Atherosclerosis and folic acid supplementation trial in chronic renal failure: baseline results.
Zoungas S; Branley P; Kerr PG; Ristevski S; Muske C; Demos L; Atkins RC; Becker G; Fraenkel M; Hutchison BG; Walker R; McNeil JJ; McGrath BP
Nephrology (Carlton); 2004 Jun; 9(3):130-41. PubMed ID: 15189174
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics of hyperhomocysteinemia in dialysis patients].
Lovcić V; Kes P; Reiner Z
Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
[TBL] [Abstract][Full Text] [Related]
7. Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations.
McGregor DO; Dellow WJ; Lever M; George PM; Robson RA; Chambers ST
Kidney Int; 2001 Jun; 59(6):2267-72. PubMed ID: 11380830
[TBL] [Abstract][Full Text] [Related]
8. Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.
Suliman ME; Stenvinkel P; Jogestrand T; Maruyama Y; Qureshi AR; Bárány P; Heimbürger O; Lindholm B
Clin Nephrol; 2006 Dec; 66(6):418-25. PubMed ID: 17176913
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients.
Fellah H; Feki M; Hsairi M; Sanhaji H; Kaabachi N; Ben Abdallah T; Massy ZA; Ben Maiz H; Lacour B; Mebazaa A
Clin Chem Lab Med; 2003 May; 41(5):675-80. PubMed ID: 12812266
[TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
[TBL] [Abstract][Full Text] [Related]
11. [Hyperhomocysteinemia and advancement of atherosclerosis in patients with chronic renal failure on maintenance hemodialysis].
Sydor A; Drozdz M; Kraśniak A; Miłkowski A; Chmiel G; Małczak J; Zabawa-Hołyś S; Moskal K; Podwysocki A; Szmigielski M; Czarnecka D; Gozdecka H; Kowalczyk-Michałek M; Szczeklik A; Wiecek A; Sułowicz W
Przegl Lek; 2002; 59(12):962-7. PubMed ID: 12731367
[TBL] [Abstract][Full Text] [Related]
12. Association between hyperhomocysteinemia and ultrasonographic atherosclerotic indices of carotid arteries in chronic hemodialysis patients.
Grekas D; Economou H; Makedou A; Destanis E; Theodoridou A; Avdelidou A; Demitriadis A; Tourkantonis A
Nephron Clin Pract; 2005; 101(4):c180-6. PubMed ID: 16103723
[TBL] [Abstract][Full Text] [Related]
13. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
Suliman ME; Stenvinkel P; Heimbürger O; Bàràny P; Lindholm B; Bergström J
Am J Kidney Dis; 2002 Sep; 40(3):480-8. PubMed ID: 12200798
[TBL] [Abstract][Full Text] [Related]
14. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
Sjöberg B; Anderstam B; Suliman M; Alvestrand A
Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
[TBL] [Abstract][Full Text] [Related]
15. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease.
Suliman ME; Lindholm B; Bárány P; Bergström J
Clin Chem Lab Med; 2001 Aug; 39(8):734-8. PubMed ID: 11592443
[TBL] [Abstract][Full Text] [Related]
17. Increased prevalence of hyperhomocysteinemia in cervical artery dissection causing stroke: a case-control study.
Benninger DH; Herrmann FR; Georgiadis D; Kretschmer R; Sarikaya H; Schiller A; Baumgartner RW
Cerebrovasc Dis; 2009; 27(3):241-6. PubMed ID: 19176957
[TBL] [Abstract][Full Text] [Related]
18. [Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients].
Armada E; Pérez Melón C; Otero A; Gayoso P; Rodríguez M; Esteban Morcillo J
Nefrologia; 2001; 21(2):167-73. PubMed ID: 11464650
[TBL] [Abstract][Full Text] [Related]
19. Plasma total homocysteine level and its association with carotid intima-media thickness in obesity.
Uysal O; Arikan E; Cakir B
J Endocrinol Invest; 2005 Nov; 28(10):928-34. PubMed ID: 16419496
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients.
Jungers P; Chauveau P; Bandin O; Chadefaux B; Aupetit J; Labrunie M; Descamps-Latscha B; Kamoun P
Miner Electrolyte Metab; 1997; 23(3-6):170-3. PubMed ID: 9387110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
